A retrospective trial comparing BMD changes between denosumab and bisphosphonates in osteoporotic patients who had completed treatment with teriparatide.

Trial Profile

A retrospective trial comparing BMD changes between denosumab and bisphosphonates in osteoporotic patients who had completed treatment with teriparatide.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 May 2016

At a glance

  • Drugs Bisphosphonates (Primary) ; Denosumab (Primary) ; Alendronic acid; Ibandronic acid; Risedronic acid; Teriparatide; Zoledronic acid
  • Indications Osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2016 New trial record
    • 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top